Ignite Creation Date:
2024-05-06 @ 3:08 AM
Last Modification Date:
2024-10-26 @ 11:29 AM
Study NCT ID:
NCT02219789
Status:
COMPLETED
Last Update Posted:
2018-10-03
First Post:
2014-08-15
Brief Title:
Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12-05
Start Date Type:
ACTUAL
Primary Completion Date:
2016-03-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-10-01
Completion Date Type:
ACTUAL
First Submit Date:
2014-08-15
First Submit QC Date:
August 18 2014
Study First Post Date:
2014-08-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-02
Last Update Post Date:
2018-10-03
Last Update Post Date Type:
ACTUAL